News Search Results
Sep 09, 2025, 07:00 ET Nektar Announces REZOLVE-AD Phase 2b Results for Rezpegaldesleukin Selected for Late-Breaker Oral Presentation at EADV 2025
the skin, leading to an immune reaction and inflammation. About Nektar Therapeutics Nektar Therapeutics is a clinical-stage biotechnology company focused on developing treatments that address the underlying immunological dysfunction in autoimmune and chronic inflammatory diseases.
More news about: Nektar Therapeutics
Sep 09, 2025, 06:32 ET Insect Pest Control Market Size Is Expected to Reach US$ 21.33 Billion By 2031 at A CAGR Of 5.4% | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Sep 09, 2025, 06:30 ET Immunic Receives Notice of Allowance for United States Patent Protecting Vidofludimus Calcium's Dose Strengths in Progressive Multiple Sclerosis
Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today
More news about: Immunic, Inc.
Sep 09, 2025, 06:30 ET Ascletis Announces Ultra-Long-Acting Subcutaneous Depot Maintenance Formulation of Small Molecule GLP-1R Agonist ASC30 Demonstrated an Observed Half-Life of 75 Days in Participants with Obesity
patent protection until 2044 without patent extensions. About Ascletis Pharma Inc. Ascletis Pharma Inc. is a fully integrated biotechnology company focused on the development and commercialization of potential best-in-class and first-in-class therapeutics to treat metabolic diseases.
More news about: Ascletis Pharma Inc.
Sep 09, 2025, 06:30 ET Global Biofortification Market Size worth USD 249 million by 2030, Backed by Policy Support and Innovation | Mordor Intelligence
nutrition security. Biofortification, the process of enhancing the nutrient profile of crops through breeding, agronomic practices, and biotechnology, has emerged as a strategic response to hidden hunger affecting over two billion people worldwide. Unlike supplementation programs, it integrates
More news about: Mordor Intelligence Private Limited
Sep 09, 2025, 01:41 ET LISCure BioSciences Secures World's First FDA NDI notification for Hair Health Probiotic Mobiome®
drive sustainable growth and deliver impactful health solutions worldwide. About LISCure BioSciencesLISCure BioSciences is a biotechnology company specializing in the development of novel therapeutics and scientifically validated functional ingredients. With a dual focus on pharmaceutical
More news about: LISCure Biosciences Inc.
Sep 08, 2025, 21:00 ET Amorepacific Group Marks 80th Anniversary: Unveils New Vision Slogan "Create New Beauty"
focusing on key global markets (Everyone Global), strengthening integrated beauty solutions (Holistic), developing anti-aging solutions based on biotechnology (Ageless), driving agile organizational innovation (AMORE Spark), and transitioning to AI-driven operations (AI First). Each of these strategies
More news about: Amorepacific
Sep 08, 2025, 21:00 ET Amorepacific Group Marks 80th Anniversary: Unveils New Vision Slogan "Create New Beauty"
focusing on key global markets (Everyone Global), strengthening integrated beauty solutions (Holistic), developing anti-aging solutions based on biotechnology (Ageless), driving agile organizational innovation (AMORE Spark), and transitioning to AI-driven operations (AI First). Each of these strategies
More news about: Amorepacific
Sep 08, 2025, 20:04 ET AMGEN AND KYOWA KIRIN ANNOUNCE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 ASCEND LONG-TERM EXTENSION STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing
More news about: Amgen
Sep 08, 2025, 19:51 ET PhotonPharma Inc. Receives U.S. Patent for Innovative Cancer Immunotherapy
COLLINS, Colo., Sept. 9, 2025 /PRNewswire/ -- PhotonPharma, a biotechnology company developing next-generation cancer immunotherapies, today announced the issuance of U.S. Patent No. 12,280,039 B2 titled "Cancer Vaccine
More news about: PhotonPharma Inc.
Sep 08, 2025, 18:43 ET MIT Technology Review Introduces the 35 Innovators Under 35 for 2025
recognize young minds that can drive global change by tackling some of the world's most pressing challenges. From advanced robotics and clean energy to biotechnology and cutting-edge computing, these innovators are at the forefront of the industries that are reshaping our daily lives. The honorees are
More news about: MIT Technology Review
Sep 08, 2025, 14:30 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain Officers - UNCY
[Click here for information about joining the class action] Unicycive is a clinical-stage biotechnology company that identifies, develops, and commercializes therapies to address unmet medical needs in the U.S. The Company is developing, among other
More news about: Pomerantz LLP
Sep 08, 2025, 12:10 ET AAVivo, Inc. to Present Precision AAV Capsid Engineering (PACE) Platform for In Vivo CAR-T Therapy at BIOHK2025
AAVivo, Inc., a pioneering biotechnology developing novel, precision targeted biotherapeutics to enable in vivo generation of CAR-T cells, today announced that Chief Technology Officer
More news about: AAVivo, Inc.
Sep 08, 2025, 11:53 ET Rubin Rudman Introduces New Brand Identity and Website
Rubin Rudman serves national and international companies, including large public companies and closely held businesses; real estate developers; biotechnology, pharmaceutical and medical device makers; regulated industries, public entities and municipalities; insurance companies and their insureds; educational
More news about: Rubin Rudman
Sep 08, 2025, 10:33 ET Liquid Biopsy Market to Reach USD 30.65 Billion by 2035, with CAGR 9.41% Driven by Rising Cancer Burden and Demand for Non-Invasive Diagnostics - Vantage Market Research
market research reports and actionable intelligence across healthcare, biotechnology, and advanced cell therapies. Our globally recognized insights empower stakeholders to make informed decisions, anticipate trends, and capitalize
More news about: Vantage Market Research
Sep 08, 2025, 10:15 ET Barbeque Grills Market Size Is Expected To Reach US$ 7.58 Billion By 2031 at A CAGR Of 5.1% |The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Sep 08, 2025, 10:01 ET Aquaculture Market Size is Expected to Reach US$ 743.90 Billion By 2031 From US$ 516.33 Billion in 2024; It Is Likely To Register A CAGR Of 5.4% | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Sep 08, 2025, 09:10 ET Made Scientific and Hemogenyx Pharmaceuticals Announce Technology Transfer and Manufacturing Partnership to Advance HG-CT-1, an Autologous CAR-T Cell Therapy for Acute Myeloid Leukemia
the global expertise and resources of GC Corporation of South Korea, a global leader in the pharmaceutical and biotechnology sectors. About Hemogenyx Pharmaceuticals Hemogenyx Pharmaceuticals is a publicly traded company (LSE: HEMO) headquartered
More news about: Made Scientific, Inc.
Sep 08, 2025, 09:00 ET Matica Biotechnology and Cirsium Biosciences Announce AAV Manufacturing Collaboration
2025 /PRNewswire/ -- Matica Biotechnology, Inc. (Matica Bio), a leading contract development and manufacturing organization (CDMO) specializing in viral vector production, and Cirsium Biosciences ("Cirsium"), a biotechnology company developing a breakthrough plant-based
More news about: Matica Biotechnology, Inc.
Sep 08, 2025, 09:00 ET Thryv Therapeutics Receives FDA IND Clearance of THRV-1268 for Clinical Programs in Heart Failure and Atrial Fibrillation and Presents Results of SGK1 Inhibition Combined with Jardiance (empagliflozin), an SGLT2 inhibitor, in a Pressure Overload Heart Failure Model at ESC Congress 2025
MONTREAL, Sept. 8, 2025 /PRNewswire/ - Thryv Therapeutics Inc., a clinical-stage biotechnology company advancing a series of novel serum glucocorticoid inducible kinase 1 (SGK1) inhibitors for cardiovascular diseases, today announced the presentation
More news about: Thryv Therapeutics Inc.
Sep 08, 2025, 09:00 ET BioMarin Shares New Data Reinforcing Its Leadership in Bone Health at the American Society for Bone and Mineral Research Annual Meeting
Patient Information. About BioMarin BioMarin is a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient. The
More news about: BioMarin Pharmaceutical Inc.
Sep 08, 2025, 08:30 ET From Bench to Batch: Potency Assays and the Importance of Antibodies, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Sep 08, 2025, 08:30 ET CGT Oncology Trials: IRB/IBC Strategies, Trends and Operational Insights, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Sep 08, 2025, 08:30 ET Successfully Moving from On-Premises QMS to SaaS eQMS, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Sep 08, 2025, 08:30 ET Xtalks Named Media Partner for KP Morgan's 9th Operational Excellence in Clinical Trials Summit in Toronto
Kovacevic, Editor-in-Chief of Xtalks. The two-day summit will convene executives, directors, managers and leaders from pharmaceutical companies, biotechnology firms, medical device organizations, CROs, academic institutions, patient advocacy groups and more. "At KP-Morgan Group, we are delighted
More news about: Xtalks